Health-related quality of life, symptoms, exercise capacity and lung function during treatment for moderate to severe COPD

Journal of Outcomes Research

Volumn 5, Issue 11-24, 2001, Pages 11-24

  Ståhl, Elisabeth ^a   Wadbo, M ^a   Bengtsson, T ^a   Strom K ^a   Lofdahl C G ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

COPD; Health related quality of life; Symptoms

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; FORMOTEROL; IPRATROPIUM BROMIDE; PLACEBO;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; COUGHING; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SIDE EFFECT; SPIROMETRY; SYMPTOM; WALKING; WELLBEING;

EID: 0035697506     PISSN: 1369698X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Quality of life measurement for patients with diseases of their airways
2. The St George's Respiratory Questionnaire
3. Effects of formoterol and ipratropium bromide in COPD - A 3-month placebo-controlled comparison of the effects of formoterol and ipratropilam bromide in patients with COPD
4. Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation
5. A self-complete measure for chronic airflow limitation: The St. George's Respiratory Questionnaire
6. Reliability and validity of a Swedish version of the St George's Respiratory Questionnaire
7. Relation of lung function, maximal inspiratory pressure, dyspnoea and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease
8. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
9. Quality of life changes in COPD patients treated with salmeterol
10. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease
11. Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting
12. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD
13. Effect of inpatient treatment on pulmonary findings and subjective well-being in patients with chronic bronchitis
14. A novel, short and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease